Situation of Drug Information Centers and Services in Costa Rica

  • Victoria Hall
  • Carolina Gomez
  • Fernando Fernandez-Llimos
Keywords: Drug information services, Costa Rica

Abstract

PAHO establishes guidelines that must be met by drug information centers (DIC) and the drug information services (DIS).

Objective: To describe the operations, activities, and resources of the DICs and the DISs affiliated with public institutions of Costa Rica, and their adjustment to the provisions set forth by the PAHO.

Methods: Descriptive study conducted in May 2003. The officers in charge of each of the seven public DICs or DISs in Costa Rica were interviewed, and inquiries were made regarding aspects of the structure and process of their centers.

Results: In Costa Rica there are seven public drug information units, that is, four DICs and three DISs. One of the DICs is located in this university, and the remaining six centers and services are in located in hospitals. Five of the centers do not have the primary sources required by the PAHO. Fifteen out of the 36 tertiary sources recommended are not available in any of the centers. 100% of the information units carry out four main activities: answering inquiries from the hospital community, answering inquiries from users outside the hospital, implementing education programs for patients and risk groups, and rotation programs for student training.

Conclusions: The activities developed by the DISs and the DICs in Costa Rica are similar to each other; they respond not only to the PAHO’s guidelines, but they also have similarities with the activities and operations of other DICs worldwide.  Primary, secondary, and tertiary bibliographical support must be strengthened.

Downloads

Download data is not yet available.

References

1 García G, Alberola C. Información sobre medicamentos. Rev AEFH. 1984; 4:5-18.

2. D´Alessio R, Busto U y Girón N. Serie de Medicamentos esenciales y tecnologías 5.4-Guía para el desarrollo de servicios farmacéuticos hospitalarios: Información de Medicamentos. Organización Panamericana de la Salud, Organización Mundial de la Salud. 1997.

3 Silva CD, Coelho HLL, Arrais PSD, Cabral FR. Drug Information Center: Contribution for rational use of drugs. Cad. Saúde Publ. 1997.13 (3): 531-535.

4 Malone P, Wilkinson K, Kier K. Stanovich J. Drug Information: A guide for pharmacist. 2 edición. USA. McGraw Hill. 2001.

5 Herrera J. Manual de Farmacia Clínica y Atención Farmacéutica. España. Elservier. 2003.

6 Millare M. Applied Drug Information: Strategies for information management. USA. Applied Therapeutics, Inc. 1998.

7 Solá N, Correa V. Uso de Fuentes de Información sobre Medicamentos. Curso de Postgrado: Introducción Práctica a la Atención Farmacéutica. Barcelona: GIAF de la Universidad de Granada; 2001.

8 Consenso sobre Atención Farmacéutica. Ministerio de Sanidad y Consumo, Dirección General de Farmacia y Productos Sanitarios. Madrid, España. 2001.

9 Anónimo. Actualidad en los Centros de Información de Medicamentos: Provincia de Álava. Panorama Actual Med 2001; 25(246): 802-805.

10 Anónimo. Actualidad en los Centros de Información de Medicamentos: Provincia de Lleida. Panorama Actual Med 2001; 25(248): 1000-1003.

11 Anónimo. Actualidad en los Centros de Información de Medicamentos: Provincia de A Coruña. Panorama Actual Med 2001; 25(241): 235-237.

12 Aguas Y, De Miguel E, Fernández-Llimós F. El seguimiento farmacoterapéutico como innovación en las farmacias comunitarias de Badajoz (España).Seguimiento Farmacoterapéutico 2005; 3(1): 10-16.

13 Anónimo. Actualidad en los Centros de Información de Medicamentos: Provincia de Girona. Panorama Actual Med 2001; 25(249):1123-1125.

14 Anónimo. Actualidad en los Centros de Información de Medicamentos: Provincia de Barcelona. Panorama Actual Med 2001; 25(240): 137-138.

15 Scala D, Bracco A, Cozzolino S, Cristinziano A, De Marino C, Di Martino A, Gonzalez E, Mancini A, Romagnuolo F, Zeuli L.. Italian drug information centers: benchmark report. Pharm World Sci 2001; 23 (6): 217-223.

16 Alberti P. Bertrand NC, Castelli M et al. CIMF: cuatro años de actividades en Argentina. Rev OFIL 1993; 3(2): 88-94.

17 Nikfar S, Abdollahi M y Cheranghali A. Cada vez más fuerte – Servicio de Información sobre Medicamentos y Tóxicos del Irán. Boletín de Medicamentos Esenciales. 2000; 28-29: 30-31.

18 Rosenberg JM, Fuentes RJ, Starr CH, Kirschenbaum HL, McGuire H.. Pharmacist-operated drug information centers in the United States. Am J Healt-Syst Pharm 1995; 52: 991-996.

19 Erbelle S, Heck A, Blankenship. Survey of computerized documentation system use in drug information centres. Am J Health-Syst Pharm 2001; 58: 695-697.

20 Crabbe S, Wordell C y Hopkins L. Fee-for-service activities provided by drug information centers. Am J Hosp Pharm 1988; 45: 1115-1117.

21 Silva EV, Castro L; Bevilaqua L et al. Centro Brasileño de Información de Medicamentos (CEBRIM): caracterización del servicio y estudio de opinión de los usuarios. Rev OFIL 2003; 13(2): 55-6.
Published
2006-07-31
How to Cite
1.
Hall V, Gomez C, Fernandez-Llimos F. Situation of Drug Information Centers and Services in Costa Rica. Pharm Pract (Granada) [Internet]. 2006Jul.31 [cited 2019Jul.17];4(2):83-7. Available from: https://pharmacypractice.org/journal/index.php/pp/article/view/290
Section
Original Research

Most read articles by the same author(s)